Quotient Wealth Partners LLC Sells 147 Shares of MetLife, Inc. (NYSE:MET)

Quotient Wealth Partners LLC cut its stake in MetLife, Inc. (NYSE:MET) by 2.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,464 shares of the financial services provider’s stock after selling 147 shares during the period. Quotient Wealth Partners LLC’s holdings in MetLife were worth $529,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. MeadowBrook Investment Advisors LLC raised its stake in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. increased its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC lifted its holdings in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new position in MetLife in the third quarter valued at about $30,000. Finally, Retirement Wealth Solutions LLC bought a new stake in MetLife during the fourth quarter worth about $32,000. Institutional investors own 94.99% of the company’s stock.

MetLife Trading Up 0.4 %

NYSE MET opened at $83.99 on Monday. MetLife, Inc. has a 12 month low of $66.18 and a 12 month high of $89.05. The stock has a 50-day simple moving average of $83.72 and a 200 day simple moving average of $80.83. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $58.16 billion, a PE ratio of 14.07, a P/E/G ratio of 0.64 and a beta of 1.07.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. Research analysts forecast that MetLife, Inc. will post 9.63 EPS for the current year.

MetLife Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be given a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.60%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 36.52%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on MET shares. TD Cowen boosted their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. BMO Capital Markets initiated coverage on MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective on the stock. JPMorgan Chase & Co. raised their target price on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company decreased their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. Finally, Barclays dropped their price objective on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.08.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.